The use of proteomics in ophthalmic research

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.1, Iss.3, 2000-08, pp. : 267-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proteomics in Urological Cancer Research

By Lawrie Laura C. Murray Graeme I.

UroOncology, Vol. 2, Iss. 4, 2002-01 ,pp. : 163-166

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Use of Proteomics to Study Infectious Diseases

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 31-45

Bentham Science Publishers

Access to resources Recommend Favorite

An update on the use of ophthalmic ketorolac tromethamine 0.4%

By Perry Henry D Donnenfeld Eric D

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 99-107

Informa Healthcare

Access to resources Recommend Favorite

Rheological evaluation of poloxamer as an in situ gel for ophthalmic use

By Edsman K. Carlfors J. Petersson R.

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 2, 1998-04 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite

Impact of proteomics on bladder cancer research

By Celis Julio E Gromova Irina Moreira Jose MA Cabezon Teresa Gromov Pavel

Pharmacogenomics, Vol. 5, Iss. 4, 2004-06 ,pp. : 381-394

Future Medicine

Access to resources Recommend Favorite